Clinical evaluation of potential usefulness of serum lactate dehydrogenase level in follow-up of small cell lung cancer | Zendy

Cheng Chen | Zendy; Ye-Han Zhu | Zendy; Jian-an Huang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical evaluation of potential usefulness of serum lactate dehydrogenase level in follow-up of small cell lung cancer

Author(s) -

Cheng Chen,

Ye-Han Zhu,

Jian-an Huang

Publication year - 2017

Publication title -

journal of cancer research and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.475

H-Index - 39

eISSN - 0973-1482

pISSN - 1998-4138

DOI - 10.4103/0973-1482.168994

Subject(s) - lactate dehydrogenase , medicine , chemotherapy , gastroenterology , lung cancer , pathological , stage (stratigraphy) , receiver operating characteristic , oncology , cancer , pathology , biology , enzyme , paleontology , biochemistry

Lactate formation is upregulated in tumor cells by lactate dehydrogenase (LDH). High serum LDH level is linked to many malignancies with poorer survival, but tumor LDH has not been well investigated in small cell lung cancer (SCLC).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research